Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7672
+0.0087 ( -2.89% ) 46.6K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7672
Previous close
$0.7585
Volume
46.6K
Market cap
$13.31M
Day range
$0.7730 - $0.8400
52 week range
$0.7200 - $5.2800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jan 04, 2024 |
| 4 | Insider transactions | 1 | Jan 04, 2024 |